Scribe Therapeutics Inc.
SCTX
IPO
$29.41
-$1.93-6.16%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Net Income | 34.60% | -406.48% | |||
| Total Depreciation and Amortization | -6.10% | -10.32% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 51.62% | 9,379.49% | |||
| Change in Net Operating Assets | -160.48% | 111.04% | |||
| Cash from Operations | 19.51% | 44.53% | |||
| Capital Expenditure | 97.72% | 96.54% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 607.39% | -27.28% | |||
| Cash from Investing | 723.71% | -25.66% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 184.31% | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -76,200.00% | -25,100.00% | |||
| Cash from Financing | -2,698.11% | -20,450.00% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 488.18% | 3.98% | |||